Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Matchmaking with consequences

17.10.2017

Myc proteins play an important role when cells become cancerous. Researchers from the University of Würzburg have studied just how they do this. They might thus open up ways to develop new therapies.

Most human tumours have one thing in common: They harbour drastically increased amounts of the so-called Myc proteins. Animal experiments show that such high Myc concentrations contribute to causing cancer.


The red dots in the right picture show where Myc and PAF1 bind to each other. This happens mainly in the cell nuclei (dyed blue).

Graphic: team Gallant

But Myc proteins not only have harmful properties, they are also crucial in healthy cells: Acting as "transcription factors", they control the activity of a limited number of genes. A lot of these genes activated by Myc are essential for the growth and proliferation of normal cells so that Myc is indispensable for normal human development.

How exactly Myc proteins work inside tumour cells has been unknown so far. Scientists from the University of Würzburg have now uncovered key details of these processes.

The study is led by Dr Peter Gallant, team leader at the Department of Biochemistry and Molecular Biology. The researchers present the results of their work in the current issue of the journal PNAS - Proceedings of the National Academy of Sciences.

Excessive Myc levels cause malignancy

"Myc proteins bind to their target genes through well-defined molecular interactions which typically contain an exactly defined sequence of nucleotides," Peter Gallant explains the basics of his study. But when Myc proteins occur in much higher concentrations, they will bind to virtually all active genes and thereby further amplify the activity of these genes, which then contributes to the affected cell becoming cancerous.

"Such behaviour is highly unusual for transcription factors and was impossible to explain in molecular terms so far," the biochemist details. According to Gallant, scientists have previously been baffled by the question of how a transcription factor, which usually only recognises short nucleotide sequences, can bind to all genes – even to such genes that do not contain this nucleotide sequence in the first place.

An enzyme acts as facilitator

The researchers found the explanation when they studied other proteins that also bind to all genes –the enzymes that read all genes and transcribe them to RNA: RNA polymerases and the associated auxiliary proteins that are important for polymerase activity. This includes the "polymerase associated factor 1" complex, short PAF1 complex, which consists of five proteins. It provided Gallant and his team answers to Myc's unusual behaviour.

The researchers used fruit flies (Drosophila melanogaster) as the model system for their studies. "Myc proteins in these insects work very similarly to mammals, but the corresponding experiments are easier and more efficient to conduct here," Gallant explains. A genetic screen showed that the PAF1 complex is important for the Myc activity – in particular for Myc's ability to activate specific target genes and to stimulate cell growth.

Advanced biochemical and molecular biological analyses, including genome-wide sequence analyses – the so-called "next-generation sequencing" – then shed light on the functioning of the PAF1 complex: Being a "polymerase-associated factor, this complex is located at virtually all active genes. At the same time, it is capable of binding to the Myc protein. "This recruits Myc proteins to active genes and can further boost their activity," Gallant explains. This stimulating effect seems to be important especially at elevated Myc levels.

Additional factors at play

In their experiments, the researchers demonstrated that while the destruction of the PAF1 complex significantly weakens the bond of the Myc proteins to their target genes, it does not eliminate it completely. "This points to the fact that there are other factors that contribute to the recruiting of Myc similarly to the PAF1 complex," Gallant explains and he says that another protein was recently identified which has similar basic functions when reading genes as the PAF1 complex and which simultaneously also binds to Myc and recruits this protein to numerous genes.

Therefore, the scientists assume that more such general factors exist that contribute to Myc's binding to all genes, and which are important particularly for abnormally elevated Myc levels.

New approach for drug development

The Würzburg scientists believe that their findings are not only of biochemical but also of medical relevance as Myc proteins play a key role in cancer development. "So far it has been impossible to develop drugs that specifically inhibit the activity of Myc proteins," Gallant explains. He is hopeful that the newly discovered interactions present potential new targets to develop drugs that selectively block Myc.

PAF1 complex component Leo1 helps recruit Drosophila Myc to promoters. Jennifer Gerlach, Michael Furrer, Maria Gallant, Dirk Birkel, Apoorva Baluapuri, Elmar Wolf, Peter Gallant. PNAS Early Edition, published online October 16. www.pnas.org/cgi/doi/10.1073/pnas.1705816114

Contact

Dr. Peter Gallant, Department of Biochemistry and Molecular Biology
Phone: +49 931 31-88814, peter.gallant@biozentrum.uni-wuerzburg.de

Gunnar Bartsch | Julius-Maximilians-Universität Würzburg
Further information:
http://www.uni-wuerzburg.de

Further reports about: Molecular Biology Myc RNA genes proteins transcription factors

More articles from Life Sciences:

nachricht New catalyst controls activation of a carbon-hydrogen bond
21.11.2017 | Emory Health Sciences

nachricht The main switch
21.11.2017 | Albert-Ludwigs-Universität Freiburg im Breisgau

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Nanoparticles help with malaria diagnosis – new rapid test in development

The WHO reports an estimated 429,000 malaria deaths each year. The disease mostly affects tropical and subtropical regions and in particular the African continent. The Fraunhofer Institute for Silicate Research ISC teamed up with the Fraunhofer Institute for Molecular Biology and Applied Ecology IME and the Institute of Tropical Medicine at the University of Tübingen for a new test method to detect malaria parasites in blood. The idea of the research project “NanoFRET” is to develop a highly sensitive and reliable rapid diagnostic test so that patient treatment can begin as early as possible.

Malaria is caused by parasites transmitted by mosquito bite. The most dangerous form of malaria is malaria tropica. Left untreated, it is fatal in most cases....

Im Focus: A “cosmic snake” reveals the structure of remote galaxies

The formation of stars in distant galaxies is still largely unexplored. For the first time, astron-omers at the University of Geneva have now been able to closely observe a star system six billion light-years away. In doing so, they are confirming earlier simulations made by the University of Zurich. One special effect is made possible by the multiple reflections of images that run through the cosmos like a snake.

Today, astronomers have a pretty accurate idea of how stars were formed in the recent cosmic past. But do these laws also apply to older galaxies? For around a...

Im Focus: Visual intelligence is not the same as IQ

Just because someone is smart and well-motivated doesn't mean he or she can learn the visual skills needed to excel at tasks like matching fingerprints, interpreting medical X-rays, keeping track of aircraft on radar displays or forensic face matching.

That is the implication of a new study which shows for the first time that there is a broad range of differences in people's visual ability and that these...

Im Focus: Novel Nano-CT device creates high-resolution 3D-X-rays of tiny velvet worm legs

Computer Tomography (CT) is a standard procedure in hospitals, but so far, the technology has not been suitable for imaging extremely small objects. In PNAS, a team from the Technical University of Munich (TUM) describes a Nano-CT device that creates three-dimensional x-ray images at resolutions up to 100 nanometers. The first test application: Together with colleagues from the University of Kassel and Helmholtz-Zentrum Geesthacht the researchers analyzed the locomotory system of a velvet worm.

During a CT analysis, the object under investigation is x-rayed and a detector measures the respective amount of radiation absorbed from various angles....

Im Focus: Researchers Develop Data Bus for Quantum Computer

The quantum world is fragile; error correction codes are needed to protect the information stored in a quantum object from the deteriorating effects of noise. Quantum physicists in Innsbruck have developed a protocol to pass quantum information between differently encoded building blocks of a future quantum computer, such as processors and memories. Scientists may use this protocol in the future to build a data bus for quantum computers. The researchers have published their work in the journal Nature Communications.

Future quantum computers will be able to solve problems where conventional computers fail today. We are still far away from any large-scale implementation,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Ecology Across Borders: International conference brings together 1,500 ecologists

15.11.2017 | Event News

Road into laboratory: Users discuss biaxial fatigue-testing for car and truck wheel

15.11.2017 | Event News

#Berlin5GWeek: The right network for Industry 4.0

30.10.2017 | Event News

 
Latest News

Previous evidence of water on mars now identified as grainflows

21.11.2017 | Physics and Astronomy

NASA's James Webb Space Telescope completes final cryogenic testing

21.11.2017 | Physics and Astronomy

New catalyst controls activation of a carbon-hydrogen bond

21.11.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>